Product NDC: | 55390-357 |
Proprietary Name: | CAFCIT |
Non Proprietary Name: | caffeine citrate |
Active Ingredient(s): | 20 mg/mL & nbsp; caffeine citrate |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 55390-357 |
Labeler Name: | Bedford Laboratories |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020793 |
Marketing Category: | NDA |
Start Marketing Date: | 20081104 |
Package NDC: | 55390-357-03 |
Package Description: | 1 VIAL in 1 BOX (55390-357-03) > 3 mL in 1 VIAL |
NDC Code | 55390-357-03 |
Proprietary Name | CAFCIT |
Package Description | 1 VIAL in 1 BOX (55390-357-03) > 3 mL in 1 VIAL |
Product NDC | 55390-357 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | caffeine citrate |
Dosage Form Name | INJECTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20081104 |
Marketing Category Name | NDA |
Labeler Name | Bedford Laboratories |
Substance Name | CAFFEINE CITRATE |
Strength Number | 20 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Central Nervous System Stimulant [EPC],Central Nervous System Stimulation [PE],Methylxanthine [EPC],Xanthines [Chemical/Ingredient] |